Revolutionizing Scientific Equipment Supply Chain through Standardization for Enhanced ESG Compliance: A Case Study on Spinco Biotech

Authors

  • Dinakar Lingam

    Department of Entrepreneurship & International Business, Research Scholar, GITAM School of Business, GITAM (Deemed to be University), Hyderabad, India

  • Dr. Syed Jaffer

    Department of Accounting and Finance, Assistant Professor, GITAM School of Business, GITAM (Deemed to be University), Hyderabad, India

How to Cite

Lingam, D. ., & Jaffer, D. S. . (2025). Revolutionizing Scientific Equipment Supply Chain through Standardization for Enhanced ESG Compliance: A Case Study on Spinco Biotech. International Journal of Accounting and Economics Studies, 12(SI-1), 324-332. https://doi.org/10.14419/b2x1hw10

Received date: June 2, 2025

Accepted date: June 14, 2025

Published date: August 28, 2025

DOI:

https://doi.org/10.14419/b2x1hw10

Keywords:

Supply Chain Standardization; Scientific Equipment Industry; ESG Compliance; Operational Efficiency; Sustainability

Abstract

This research considers the important position that standardization initiatives hold in the supply chain of the pharmaceutical sector. It considers the challenges encountered and the increasing importance of adhering to Environmental, Social, and Governance (ESG) standards in this sector. The study illustrates how standardized approaches can be implemented to improve operational efficiency and maintain ethical governance. A thorough analysis of relevant research demonstrates how important it is for scientific equipment supply chains to be resilient, efficient, and multinational in their operation. It also shows how ESG compliance has evolved from a side concern to a crucial component of corporate strategy. Important insights into how standardization procedures might be integrated with operational effectiveness and ESG compliance can be gained from Spinco Biotech. This research validates the advantages of standardization on different supply chain activities, including distribution, inventory, logistics, and procurement, all of which contribute to business performance and ESG compliance. It also throws light on the difficulties that still exist, but also highlights the strategies that were created along the way. This study fills gaps in the literature base and calls for further intensive research in supply chain standardization and ESG compliance, thereby supporting sustainable development in the scientific equipment industry.

References

  1. Abdolazimi, O., Salehi Esfandarani, M., Salehi, M., Shishebori, D., & Shakhsi-Niaei, M. (2023). Development of sustainable and resilient healthcare and non-cold pharmaceutical distribution supply chain for COVID-19 pandemic: A case study. The International Journal of Logistics Management, 34(2), 363–389. https://doi.org/10.1108/IJLM-04-2021-0232
  2. Abrol, D., Prajapati, P., & Singh, N. (2011). Globalization of the Indian pharmaceutical industry: Implications for innovation. Institutions and Economies, 3(3), 327–365.
  3. Ahmad, A. Y. A. B., Kumari, S. S., MahabubBasha, S., Guha, S. K., Gehlot, A., & Pant, B. (2023, January). Blockchain implementation in finan-cial sector and cyber security system. In 2023 International Conference on Artificial Intelligence and Smart Communication (AISC) (pp. 586–590). IEEE. https://doi.org/10.1109/AISC56616.2023.10085045
  4. Almashaqbeh, H. A., Ramachandran, K. K., Guha, S. K., Basha, M., & Nomani, M. Z. M. (2024). The advancement of using Internet of Things in blockchain applications for creating sustainable environment in the real world scenario. In Computer Science Engineering and Emerging Technolo-gies: Proceedings of ICCS 2022 (p. 278).
  5. Asim, M., & Nasim, S. (2017). Flexibility and competitiveness in Indian pharmaceutical industry: A theoretical perspective. South Asian Journal of Marketing & Management Research, 7(6), 70–88.
  6. Barko, T., Cremers, M., & Renneboog, L. (2022). Shareholder engagement on environmental, social, and governance performance. Journal of Busi-ness Ethics, 180, 777–812. https://doi.org/10.1007/s10551-021-04850-z
  7. Bastani, P. (2019). Challenges of the pharmaceutical supply chain in a developing country: A qualitative study. Tehran University of Medical Sci-ences Journal, 43(3), 179–185.
  8. Bastani, P., Sadeghkhani, O., Ravangard, R., et al. (2021). Designing a resilience model for pharmaceutical supply chain during crises: A grounded theory approach. Journal of Pharmaceutical Policy and Practice, 14, 115. https://doi.org/10.1186/s40545-021-00399-4
  9. Bravo, A. M. S., & De Carvalho, J. C. (2015). Challenging times to pharmaceutical supply chains towards sustainability: A case study application. International Journal of Procurement Management, 8(1–2), 126–140.
  10. Chaturvedi, U. (2017). Evolution and adoption of sustainable practices in the pharmaceutical industry: An overview with an Indian perspective. Journal of Cleaner Production, 168, 1358–1369.
  11. Das, S., & Sarkar, A. (2023). Understanding the factors promoting sustainability in the Indian pharmaceutical sector through ESG approach. Amer-ican Journal of Theoretical and Applied Business, 9(1), 17–20.
  12. Dawra, A., Ramachandran, K. K., Mohanty, D., et al. (2024). Enhancing business development, ethics, and governance with the adoption of dis-tributed systems. In Meta Heuristic Algorithms for Advanced Distributed Systems (pp. 193–209). https://doi.org/10.1002/9781394188093.ch12
  13. Ding, B. (2018). Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical supply chains. Process Safety and Environmental Protection, 119, 115–130. https://doi.org/10.1016/j.psep.2018.06.031
  14. Dutta, P. (2020). Blockchain technology in supply chain operations: Applications, challenges and research opportunities. Transportation Research Part E: Logistics and Transportation Review, 142, 102067. https://doi.org/10.1016/j.tre.2020.102067
  15. Faggioni, F., Rossi, M., & Sestino, A. (2023). Supply chain resilience in the pharmaceutical industry: A qualitative analysis from scholarly and man-agerial perspectives. International Journal of Business and Management, 18(1), 129–146. https://doi.org/10.5539/ijbm.v18n1p129
  16. Ghadge, A., Bourlakis, M., Kamble, S., & Seuring, S. (2023). Blockchain implementation in pharmaceutical supply chains: A review and conceptual framework. International Journal of Production Research, 61(19), 6633–6651. https://doi.org/10.1080/00207543.2022.2125595
  17. Gupta, H., & Kayande, R. A. (2023). Enhancing pharmaceutical supply chain resilience: A study of pharmaceutical companies in multiple geogra-phies. Indian Journal of Pharmaceutical Education and Research, 57(2), 603–611.
  18. Herold, D., Nowicka, K., Pluta-Zaremba, A., & Kummer, S. (2021). COVID-19 and the pursuit of supply chain resilience: Reactions and “lessons learned” from logistics service providers (LSPs). Supply Chain Management: An International Journal. Advance online publication. https://doi.org/10.1108/SCM-09-2020-0439
  19. Hossain, A. B. M. A., Siddiqua, A., Islam, M. E., Kabir, S. M. H., & Mahdi, G. M. A. (2024). Economic supply chain analysis of Hilsa Fish Land-ing Centers (Maach Ghats) in Bangladesh: Operational insights and strategies. International Journal of Aquatic Research and Environmental Stud-ies, 4(2), 69–88. http://doi.org/10.70102/IJARES/V4I2/5
  20. Ivanov, D. (2020). Predicting the impacts of epidemic outbreaks on global supply chains: A simulation-based analysis on the coronavirus outbreak (COVID-19/SARS-CoV-2) case. Transportation Research Part E: Logistics and Transportation Review, 136, 101922. https://doi.org/10.1016/j.tre.2020.101922
  21. Jaberidoost, M. (2013). Pharmaceutical supply chain risks: A systematic review. DARU Journal of Pharmaceutical Sciences, 21, 69. https://doi.org/10.1186/2008-2231-21-69
  22. Jain, S., & Suresh, N. (2024). Membrane technologies in juice clarification: Comparative study of UF and NF systems. Engineering Perspectives in Filtration and Separation, 2(3), 1–4.
  23. Henrichs, E., Boller, M. L., Stolz, J., & Krupitzer, C. (2025). Quantum of trust: Overview of blockchain technology for product authentication in food and pharmaceutical supply chains. Trends in Food Science & Technology, 104892. https://doi.org/10.1016/j.tifs.2025.104892
  24. Belal, M.M., Shukla, V., Ahmad, S. and Balasubramanian, S. (2025), "Green pharma supply chain: a review of existing practices and future direc-tions", Management of Environmental Quality, Vol. 36 No. 1, pp. 72-106. https://doi.org/10.1108/MEQ-08-2023-0249.
  25. Kalyan, N. B., et al. (2023, September). Application of Internet of Things and machine learning in improving supply chain financial risk manage-ment system. In 2023 IEEE 2nd International Conference on Industrial Electronics: Developments & Applications (ICIDeA) (pp. 211–216). IEEE.
  26. Kaufman, L., Gore, K., & Zandee, J. C. (2016). Data standardization, pharmaceutical drug development, and the 3Rs. ILAR Journal, 57(2), 109–119. https://doi.org/10.1093/ilar/ilw030
  27. Koh, R., Schuster, E. W., Chackrabarti, I., & Bellman, A. (2003). Securing the pharmaceutical supply chain. White Paper, Auto-ID Labs, Massa-chusetts Institute of Technology, 1, 19.
  28. Kotti, J., Ganesh, C. N., Naveenan, R. V., Gorde, S. G., S., M. B., Pramanik, S., & Gupta, A. (2024). Utilizing Big Data Technology for Online Financial Risk Management. In M. Tavares, G. Azevedo, J. Vale, R. Marques, & M. Bastos (Eds.), Artificial Intelligence Approaches to Sustainable Accounting (pp. 135-148). IGI Global Scientific Publishing. https://doi.org/10.4018/979-8-3693-0847-9.ch008
  29. Lawa, S., & Krishnan, R. (2020). Policy review in attribute-based access control: A policy machine case study. Journal of Internet Services and In-formation Security, 10(2), 67–81.
  30. Li, S., Nathan, R., Ragu-Nathan, T. S., & Rao, S. S. (2006). The impact of supply chain management practices on competitive advantage and organ-izational performance. Omega, 34(2), 107–124. https://doi.org/10.1016/j.omega.2004.08.002
  31. López-Toro, A. A. (2021). Influence of ESGC indicators on financial performance of listed pharmaceutical companies. International Journal of En-vironmental Research and Public Health, 18(9), 4556. https://doi.org/10.3390/ijerph18094556
  32. Mehralian, G., Zarenezhad, F., & Ghatari, A. (2015). Developing a model for an agile supply chain in pharmaceutical industry. International Journal of Pharmaceutical and Healthcare Marketing, 9(1), 74–91. https://doi.org/10.1108/IJPHM-09-2013-0050
  33. Moosivand, A., et al. (2019). Supply chain challenges in pharmaceutical manufacturing companies: Using qualitative system dynamics methodology. Iranian Journal of Pharmaceutical Research, 18(2), 1103–1116. https://doi.org/10.22037/ijpr.2019.2389
  34. Rana, S., Sheshadri, T., Malhotra, N., & Mahabub Basha, S. (2024). Creating Digital Learning Environments: Tools and Technologies for Success. In R. Kumar, E. Ong, S. Anggoro, T. Toh, & M. Fukui (Eds.), Transdisciplinary Teaching and Technological Integration for Improved Learning: Case Studies and Practical Approaches (pp. 1-21). IGI Global Scientific Publishing. https://doi.org/10.4018/979-8-3693-8217-2.ch001
  35. Rao, N., & Tiwari, M. (2023). Nature-based solutions for coastal resilience: Case studies from Southeast Asia. International Journal of SDG’s Pro-spects and Breakthroughs, 1(1), 8–10.
  36. Rao, P., & Holt, D. (2005). Do green supply chains lead to competitiveness and economic performance? International Journal of Operations & Pro-duction Management, 25(9), 898–916. https://doi.org/10.1108/01443570510613956
  37. Rossetti, C. L., Handfield, R., & Dooley, K. J. (2011). Forces, trends, and decisions in pharmaceutical supply chain management. International Journal of Physical Distribution & Logistics Management, 41(6), 601–622. https://doi.org/10.1108/09600031111147835
  38. Sarkar, P. (2024, November). Neural networks for portfolio management optimization. In 2024 Second International Conference on Computational and Characterization Techniques in Engineering & Sciences (IC3TES) (pp. 1–5). IEEE. https://doi.org/10.1109/IC3TES62412.2024.10877590
  39. Settanni, E., Harrington, T., & Srai, J. (2017). Pharmaceutical supply chain models: A synthesis from a systems view of operations research. Opera-tions Research Perspectives, 4, 36–50. https://doi.org/10.1016/j.orp.2017.05.002
  40. Seyvanizad, J. (2017). Authoritative Order, Legal Status and Constitutional Law. International Academic Journal of Social Sciences, 4(1), 1–8.
  41. Shah, N. (2004). Pharmaceutical supply chains: Key issues and strategies for optimisation. Computers & Chemical Engineering, 28(6–7), 929–941. https://doi.org/10.1016/j.compchemeng.2003.09.022
  42. Singh, A. (2023, December). Design and implementation of blockchain-based technology for supply chain quality management: Challenges and op-portunities. In 2023 4th International Conference on Computation, Automation and Knowledge Management (ICCAKM) (pp. 01–06). IEEE.
  43. Singh, R., Kumar, R., & Kumar, P. (2016). Strategic issues in pharmaceutical supply chain: A review. International Journal of Pharmaceutical and Healthcare Marketing, 10. https://doi.org/10.1108/IJPHM-10-2015-0050
  44. Su, X., Wang, S., & Li, F. (2023). The impact of digital transformation on ESG performance based on the mediating effect of dynamic capabilities. Sustainability, 15, 13506. https://doi.org/10.3390/su151813506
  45. Tamannaeifar, M. R., Moradi, S., & Golmohamadi, S. (2015). Compare the Emotional Intelligence and Irrational beliefs In Addicted Individuals and normal. International Academic Journal of Organizational Behavior and Human Resource Management, 2(2), 75–84.
  46. Tassey, G. (2000). Standardization in technology-based markets. Research Policy, 29(4–5), 587–602. https://doi.org/10.1016/S0048-7333(99)00091-8
  47. Zhang, J., & Song, X. (2024). The AI-assisted traditional design methods for the construction sustainability: A case study of the Lisu ethnic minori-ty village. Natural and Engineering Sciences, 9(2), 213–233. https://doi.org/10.28978/nesciences.1569562
  48. Rahman, F. (2023). Cloud-native microservices for next-gen computing applications and scalable architectures. Electronics, Communications, and Computing Summit, 1(1), 39–48.
  49. Uvarajan, K. P. (2025). Design of a hybrid renewable energy system for rural electrification using power electronics. National Journal of Electrical Electronics and Automation Technologies, 1(1), 24–32.
  50. Veerappan, S. (2025). Harmonic feature extraction and deep fusion networks for music genre classification. National Journal of Speech and Audio Processing, 1(1), 37–44.
  51. Madhanraj. (2025). Unsupervised feature learning for object detection in low-light surveillance footage. National Journal of Signal and Image Pro-cessing, 1(1), 34–43.
  52. Poornimadarshini, S. (2024). Multi-layer security framework using RF fingerprinting and lightweight protocols in wireless networks. National Jour-nal of RF Circuits and Wireless Systems, 1(1), 39–48.
  53. Abdullah, D. (2024). Strategies for low-power design in reconfigurable computing for IoT devices. SCCTS Transactions on Reconfigurable Com-puting, 1(1), 21-25. https://doi.org/10.31838/RCC/01.01.05
  54. Rahim, R. (2025). Investigation of phase change material (PCM) integration in metal foam heat sinks for thermal regulation of high-power microe-lectronics. Advances in Mechanical Engineering and Applications, 1(2), 11–19.

Downloads

How to Cite

Lingam, D. ., & Jaffer, D. S. . (2025). Revolutionizing Scientific Equipment Supply Chain through Standardization for Enhanced ESG Compliance: A Case Study on Spinco Biotech. International Journal of Accounting and Economics Studies, 12(SI-1), 324-332. https://doi.org/10.14419/b2x1hw10

Received date: June 2, 2025

Accepted date: June 14, 2025

Published date: August 28, 2025